News & Updates
Filter by Specialty:
HK’s first territory-wide long COVID study to inform follow-up care
Researchers at the Chinese University of Hong Kong (CUHK) have rolled out the city’s first territory-wide study of long COVID to inform multidisciplinary follow-up care for thousands of COVID-19 survivors. Participants are also invited to a second-phase 3-year prospective study of the impact of gut dysbiosis on long COVID symptoms and the potential role of gut microbiome modulation in treatment of long COVID.
HK’s first territory-wide long COVID study to inform follow-up care
01 Aug 2022
Timing of liquid LT4 intake doesn’t impact bioavailability
Bioavailability studies presented at ENDO 2022 showed that patients with hypothyroidism can safely take the liquid formulations of levothyroxine (LT4) 15 or 30 minutes before meals, without having to worry about food effect on bioavailability.
Timing of liquid LT4 intake doesn’t impact bioavailability
01 Aug 2022
Men with untreated hypogonadism at risk of long-term morbidity, death
Untreated hypogonadism in men appears to elevate the risk of morbidity in the long term and early mortality based on time-related measures of risk only, according to a study.
Men with untreated hypogonadism at risk of long-term morbidity, death
31 Jul 2022
Thyroid hormone sensitivity tied to advanced liver fibrosis in NAFLD
In euthyroid patients with nonalcoholic fatty liver disease (NAFLD), higher values of thyroid hormone sensitivity markers, such as the thyroid-stimulating hormone (TSH) index (TSHI) and thyroid feedback quantile-based index (TFQI), appear to aggravate the risk of advanced fibrosis, a recent study has found.